| Edronax® 4 mg tablets PA0822/127/001 |
Reboxetine |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| EDURANT 2.5 mg film-coated tablets EU/1/11/736/002 |
Rilpivirine |
Janssen-Cilag International NV |
— |
| EDURANT 25 mg film-coated tablets EU/1/11/736/001 |
Rilpivirine hydrochloride |
Janssen-Cilag International NV |
— |
| Efavirenz Teva 600 mg film-coated tablets EU/1/11/742/001-010 |
Efavirenz |
Teva B.V. |
— |
| Efavirenz/Emtricitabine/Tenofovir disoproxil Krka 600 mg/200 mg/245 mg film-coated tablets EU/1/17/1263/001-002 |
Tenofovir disoproxil succinate, Efavirenz, Emtricitabine |
KRKA, d.d., Novo mesto |
— |
| Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan 600 mg/200 mg/245 mg film-coated tablets EU/1/17/1222/001-002 |
Efavirenz, Tenofovir disoproxil maleate, Emtricitabine |
Mylan Pharmaceuticals Limited |
— |
| Efavirenz/Emtricitabine/Tenofovir disoproxil Teva 600 mg/200 mg/245 mg Film-coated Tablets PA1986/033/001 |
Efavirenz, Emtricitabine, Tenofovir disoproxil |
Teva B.V. |
Marketed |
| Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva 600 mg/200 mg/245 mg film-coated tablets EU/1/17/1210/001 |
Tenofovir disoproxil phosphate, Efavirenz, Emtricitabine |
Zentiva k.s. |
— |
| Efexor XL 150 mg prolonged-release capsules, hard PA23355/002/003 |
Venlafaxine hydrochloride |
Viatris Healthcare Limited |
Marketed |
| Efexor XL 150 mg prolonged-release capsules, hard PPA0465/085/005 |
Venlafaxine hydrochloride |
PCO Manufacturing Ltd. |
— |
| Efexor XL 37.5 mg prolonged-release capsules, hard PA23355/002/001 |
Venlafaxine hydrochloride |
Viatris Healthcare Limited |
Marketed |
| Efexor XL 75 mg prolonged-release capsules, hard PA23355/002/002 |
Venlafaxine hydrochloride |
Viatris Healthcare Limited |
Marketed |
| Efexor XL 75 mg prolonged-release capsules, hard PPA0465/085/003 |
Venlafaxine |
PCO Manufacturing Ltd. |
— |
| Effentora 100 micrograms buccal tablets EU/1/08/441/1-2 |
FENTANYL CITRATE |
Phoenix Labs |
— |
| Effentora 200 micrograms buccal tablets EU/1/08/441/3-4 |
FENTANYL CITRATE |
Phoenix Labs |
— |
| Effentora 400 micrograms buccal tablets EU/1/08/441/5-6 |
FENTANYL CITRATE |
Phoenix Labs |
— |
| Effentora 600 micrograms buccal tablets EU/1/08/441/7-8 |
FENTANYL CITRATE |
Phoenix Labs |
— |
| Effentora 800 micrograms buccal tablets EU/1/08/441/9-10 |
FENTANYL CITRATE |
Phoenix Labs |
— |
| Efficib 50 mg/1000 mg film-coated tablets EU/1/08/457/8-14 |
Sitagliptin phosphate, Metformin Hydrochloride |
Merck Sharp & Dohme BV |
— |
| Efficib 50 mg/850 mg film-coated tablets EU/1/08/457/1-7 |
Sitagliptin phosphate, Metformin Hydrochloride |
Merck Sharp & Dohme BV, |
— |
| Efient 10 mg Film-coated tablet EU/1/08/503/8-14 |
Prasugrel hydrochloride |
Substipharm |
— |
| Efient 5 mg Film-coated tablet EU/1/08/503/1-7 |
Prasugrel hydrochloride |
Substipharm |
— |
| Efluelda suspension for injection in pre-filled syringe Trivalent influenza vaccine (split virion, inactivated), 60 micrograms HA/strain PA23458/001/001 |
Influenza Inactivated Split Virus Strain A (H1N1), Influenza Inactivated Split Virus Strain A (H3N2), Influenza Inactivated Split Virus Strain B |
Sanofi Winthrop Industrie |
Not marketed |
| Efluelda Tetra, suspension for injection in pre-filled syringe PA23458/012/001 |
Influenza Inactivated Split Virus Strain B, Influenza Inactivated Split Virus Strain A (H3N2), Influenza Inactivated Split Virus Strain B, Influenza Inactivated Split Virus Strain A (H1N1) |
Sanofi Winthrop Industrie |
Not marketed |
| Efmody EU/1/21/1549/003 |
Hydrocortisone |
Diurnal Europe B.V. |
— |
| Efmody 10 mg modified-release hard capsules EU/1/21/1549/002 |
Hydrocortisone |
Diurnal Europe B.V. |
— |
| Efmody 5 mg modified-release hard capsules EU/1/21/1549/001 |
Hydrocortisone |
Diurnal Europe B.V. |
— |
| EFRACEA 40 mg modified-release hard capsules PA22743/006/001 |
Doxycycline |
Galderma International |
Marketed |
| Efudix 5 % w/w Cream PA23355/026/001 |
Fluorouracil |
Viatris Healthcare Limited |
Marketed |
| Egostar 22400 IU film-coated tablets PA23312/001/001 |
Vitamin d3 |
Jaba Recordati S.A. |
Marketed |
| Ejulir 6 mg/ml solution for injection in pre-filled pen PA23266/080/001 |
Liraglutide |
Viatris Limited |
Not marketed |
| Eklira Genuair 322 micrograms inhalation powder EU/1/12/778/001-003 |
Micronized aclidinium bromide |
Covis Pharma Europe B.V. |
— |
| Ekterly 300 mg film-coated tablets EU/1/25/1975/001-002 |
Sebetralstat |
Kalvista Pharmaceuticals (Ireland) Limited |
— |
| Eladynos 80 micrograms/dose solution for injection in pre-filled pen EU/1/22/1706/001 |
Abaloparatide |
Theramex Ireland Limited |
— |
| ELAHERE 5 mg/mL concentrate for solution for infusion EU/1/24/1866/001 |
Mirvetuximab soravtansine |
Immunogen Biopharma (Ireland) Limited |
— |
| Elantan 20 mg Tablets PA2118/002/003 |
Isosorbid-5-mononitrat |
Merus Labs Luxco II S.à.R.L. |
Marketed |
| Elantan LA 25mg Prolonged Release Capsules PA2118/002/005 |
ISOSORBIDE MONONITRATE |
Merus Labs Luxco II S.à.R.L. |
Marketed |
| Elantan LA 50 mg Prolonged Release Capsules, hard PA2118/002/004 |
ISOSORBIDE MONONITRATE |
Merus Labs Luxco II S.à.R.L. |
Marketed |
| Elaprase 2 mg/ml concentrate for solution for infusion EU/1/06/365/1-3 |
Idursulfase |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| Eldepryl 5 mg Tablets PA1327/003/001 |
Selegiline hydrochloride |
Orion Corporation |
Marketed |
| Elebrato Ellipta 92 micrograms/55 micrograms/22 micrograms inhalation powder, pre-dispensed EU/1/17/1237/001-003 |
Fluticasone furoate, Umeclidinium bromide, Vilanterol trifenatate |
GlaxoSmithKline Trading Services Limited |
— |
| Eletriptan 20mg Film-coated tablet PA0688/048/001 |
ELETRIPTAN |
Chanelle Medical Unlimited Company |
Not marketed |
| Eletriptan 40mg Film-coated tablet PA0688/048/002 |
ELETRIPTAN |
Chanelle Medical Unlimited Company |
Not marketed |
| Elfabrio 2 mg/ml Concentrate for solution for infusion EU/1/23/1724/001-003 |
Pegunigalsidase Alfa |
Chiesi Farmaceutici S.p.A. |
— |
| ELIGARD 22.5 mg powder and solvent for solution for injection PA0812/005/002 |
Leuprorelin acetate |
Recordati Industria Chimica e Farmaceutica SpA |
Marketed |
| ELIGARD 22.5 mg powder and solvent for solution for injection PPA2306/036/001 |
Leuprorelin acetate |
Originalis B.V. |
— |
| ELIGARD 22.5 mg powder and solvent for solution for injection PPA0465/511/001 |
Leuprorelin acetate |
PCO Manufacturing Ltd. |
— |
| ELIGARD 22.5 mg powder and solvent for solution for injection PPA25370/004/001 |
Leuprorelin acetate |
BModesto B.V. |
— |
| ELIGARD 45 mg powder and solvent for solution for injection PA0812/005/003 |
Leuprorelin acetate |
Recordati Industria Chimica e Farmaceutica SpA |
Marketed |
| ELIGARD 45 mg powder and solvent for solution for injection PPA0465/511/002 |
Leuprorelin acetate |
PCO Manufacturing Ltd. |
— |